全部照片(4)
About This Item
線性公式:
H2NCOCH2N(CH2CO2H)2
CAS號碼:
分子量：:
190.15
Beilstein:
1787181
EC號碼:
MDL號碼:
分類程式碼代碼:
12161700
PubChem物質ID:
NACRES:
NA.25
推薦產品
化驗
≥98% (titration)
形狀
powder
pH值
1.5-3.0
有用的pH值範圍
6.0-7.2
pKa (25 °C)
6.6
mp
219 °C (dec.) (lit.)
溶解度
1 M NaOH: 160 mg/mL, clear, colorless
應用
diagnostic assay manufacturing
儲存溫度
room temp
SMILES 字串
NC(=O)CN(CC(O)=O)CC(O)=O
InChI
1S/C6H10N2O5/c7-4(9)1-8(2-5(10)11)3-6(12)13/h1-3H2,(H2,7,9)(H,10,11)(H,12,13)
InChI 密鑰
QZTKDVCDBIDYMD-UHFFFAOYSA-N
尋找類似的產品？ 前往 產品比較指南
一般說明
ADA是一种可用于生物化学和分子生物学的两性离子缓冲剂。它是在1960′年代开发的Good缓冲液之一，可为广泛的生化研究应用提供6.15 - 8.35的pH缓冲范围。Good及其同事在其开创性的报道中对ADA的合成及物理性质进行了描述。ADA缓冲液在水溶液中的可用范围是6.0 - 7.2。
應用
含氢氧化钠和氯化钠（pH 5.67-7.57，有效pH范围6.4-7.4）的生物缓冲液组分。用于制备固相pH梯度。
準備報告
该产品可溶于1 M NaOH（160mg/mL），产生澄清无色的溶液。
訊號詞
Warning
危險聲明
危險分類
Acute Tox. 4 Oral
儲存類別代碼
13 - Non Combustible Solids
水污染物質分類（WGK）
WGK 3
閃點（°F）
Not applicable
閃點（°C）
Not applicable
個人防護裝備
Eyeshields, Gloves, type N95 (US)
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號，寫有 ‘Lot’或‘Batch’.。
Hydrogen ion buffers for biological research
Good NE, et al.
Biochemistry, 5( (2), 467-477 (1966)
Gulen Yesilbag Tonga et al.
Nature chemistry, 7(7), 597-603 (2015-06-24)
Bioorthogonal catalysis broadens the functional possibilities of intracellular chemistry. Effective delivery and regulation of synthetic catalytic systems in cells are challenging due to the complex intracellular environment and catalyst instability. Here, we report the fabrication of protein-sized bioorthogonal nanozymes through
Johannan F Brandse et al.
Journal of Crohn's & colitis, 9(11), 973-981 (2015-06-28)
High serum concentrations of infliximab [IFX] and adalimumab [ADA] may be associated with adverse effects in patients with inflammatory bowel disease [IBD]. We aimed to investigate whether high anti-tumour necrosis factor [TNF] trough levels [TLs] were associated with toxicity and
Harold Bays et al.
The Journal of clinical endocrinology and metabolism, 100(8), 3140-3148 (2015-06-02)
Despite current standard of care, many patients at high risk of cardiovascular disease (CVD) still have elevated low-density lipoprotein cholesterol (LDL-C) levels. Alirocumab is a fully human monoclonal antibody inhibitor of proprotein convertase subtilisin/kexin type 9. The objective of the
D M Bers et al.
The American journal of physiology, 260(5 Pt 1), C900-C909 (1991-05-01)
Extracellular Ca (Cao) depletions that occur during cardiac muscle contractions are indicative of net Ca entry. Buffering Cao concentration ([Ca]o) with citrate can limit the magnitude of these Cao depletions [e.g., Shattock and Bers. Am. J. Physiol. 256 (Cell Physiol.
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務